OMADA HEALTH INC

OMADA Health insider sale: President Shao Wei‑Li sold 8,866 shares at $25.02, showing routine divestiture amid steady fundamentals and positive investor sentiment.

CEO Sean P. Duffy’s recent OMADA Health 10‑B5‑1 trades reveal a disciplined, long‑term confidence in the company’s rally and a strategy to lock in gains while aligning with shareholders.

CEO Sean Duffy’s 10(b)(5)(1) buy‑sell on OMADA shares shows insider confidence yet highlights short‑term gains – what this means for investors.

Insider buying fuels optimism at OMADA Health—Hilleman Jeryl’s RSU correction shows strong confidence and points to continued upside in virtual care.

OMADA insiders, led by Gracey Craig, trade aggressively—buy low, sell high, and exercise options—to capitalize on a 3.26% rally, signaling confidence while managing liquidity.

CEO Sean Duffy’s 2,800‑share OMADA Health buy signals insider confidence and hints at future bullish moves, even amid social‑media buzz.

Insight: Gracey Craig’s 10(b)(5) buy at OMADA Health signals confidence amid a rally—watch insider trades for clues on future upside.

Insightful analysis of Gracey Craig’s June 2026 OMADA shares sales: why insider selling matters for long‑term investors and the stock’s bullish outlook.

OMADA Health CEO Sean Duffy’s steady, low‑volume sales reveal a disciplined, rule‑based trading plan that keeps long‑term confidence intact.

OMADA Health insider sales stay low‑volume and rule‑compliant, hinting at confidence rather than distress—investors can gauge future filing patterns for clues.